» Articles » PMID: 1873853

Growth Factors and Tyrosine Protein Kinases in Normal and Malignant Melanocytes

Overview
Specialty Oncology
Date 1991 Jun 1
PMID 1873853
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Melanomas are highly variable with respect to aberrant gene expression and chromosomal lesions but share a common characteristic of an acquired independence from environmental growth factors that are needed for proliferation of normal melanocytes. Receptors with tyrosine kinase activity play a critical role in normal melanocyte proliferation and in the uncontrolled growth of melanomas. Normal human melanocytes depend on exogenous peptide growth factors such as basic fibroblast growth factor (bFGF), hepatocyte growth factor (HGF), or mast cell growth factor (MGF), all of which stimulate receptors with tyrosine kinase activity. In contrast, human melanoma cells from primary nodular and metastatic lesions grow autonomously partially because of inappropriate production of bFGF and continuous activation of the bFGF-receptor kinase. Animal models also provide evidence for the importance of receptor-tyrosine kinases in normal melanocyte proliferation and in malignant transformation. In the mouse, genes residing in three loci in which inactivation mutations lead to piebaldism, the dominant spotting (W), patch (Ph), and Sl encode, respectively, the receptor-kinases c-kit and platelet derived growth factor receptor, and the ligand for c-kit: MGF. In vivo transformation of mouse melanocytes to melanoma, due to constitutive expression of a transmembrane tyrosine kinase, the oncogene ret, was recently demonstrated in transgenic mice. Studies on a fish model, Xiphophorus, in which melanoma is inherited, showed that the dominant tumor inducing gene, Tu, encodes an EGF-receptor related tyrosine kinase which is expressed only in melanomas and not in normal tissues. Taken together, the results suggest that the uncontrolled growth of melanomas is due, in large part, to constitutive activation of receptors with tyrosine kinase activity.

Citing Articles

A point mutation in the extracellular domain of KIT promotes tumorigenesis of mast cells via ligand-independent auto-dimerization.

Amagai Y, Matsuda A, Jung K, Oida K, Jang H, Ishizaka S Sci Rep. 2015; 5:9775.

PMID: 25965812 PMC: 4428273. DOI: 10.1038/srep09775.


Establishment of a novel melanoma cell line SMYM-PRGP showing cytogenetic and biological characteristics of the radial growth phase of acral melanomas.

Murata H, Ashida A, Takata M, Yamaura M, Bastian B, Saida T Cancer Sci. 2007; 98(7):958-63.

PMID: 17488338 PMC: 11159257. DOI: 10.1111/j.1349-7006.2007.00496.x.


FGF-18, a novel member of the fibroblast growth factor family, stimulates hepatic and intestinal proliferation.

Hu M, Qiu W, Wang Y, Hill D, Ring B, Scully S Mol Cell Biol. 1998; 18(10):6063-74.

PMID: 9742123 PMC: 109192. DOI: 10.1128/MCB.18.10.6063.


A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.

Morrison M, Vijayasaradhi S, Engelstein D, Albino A, Houghton A J Exp Med. 1993; 177(4):1135-43.

PMID: 8096237 PMC: 2190962. DOI: 10.1084/jem.177.4.1135.


Expression of c-kit ligand in human keratinocytes.

Morita E, Lee D, Sugiyama M, Yamamoto S Arch Dermatol Res. 1994; 286(5):273-7.

PMID: 7520225 DOI: 10.1007/BF00387600.

References
1.
Cowan J, Halaban R, Francke U . Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. J Natl Cancer Inst. 1988; 80(14):1159-64. DOI: 10.1093/jnci/80.14.1159. View

2.
Anderson D, Lyman S, Baird A, Wignall J, Eisenman J, Rauch C . Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell. 1990; 63(1):235-43. DOI: 10.1016/0092-8674(90)90304-w. View

3.
Friesel R, Burgess W, Maciag T . Heparin-binding growth factor 1 stimulates tyrosine phosphorylation in NIH 3T3 cells. Mol Cell Biol. 1989; 9(5):1857-65. PMC: 362976. DOI: 10.1128/mcb.9.5.1857-1865.1989. View

4.
Anders F, Schartl M, Barnekow A, Anders A . Xiphophorus as an in vivo model for studies on normal and defective control of oncogenes. Adv Cancer Res. 1984; 42:191-275. DOI: 10.1016/s0065-230x(08)60459-5. View

5.
Burgess W, Maciag T . The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem. 1989; 58:575-606. DOI: 10.1146/annurev.bi.58.070189.003043. View